MN SF4084

Establishes the Prescription Drug Price Transparency Act requiring pharmaceutical manufacturers to report prescription drug pricing information to the Minnesota Commissioner of Health.

Requires manufacturers to report 60 days in advance for drugs priced over $40 per course of therapy with price increases exceeding 10% in 12 months or 16% in 24 months, including wholesale acquisition costs, price history, contributing factors, and direct costs breakdown.

Requires manufacturers to report new prescription drugs priced over $500 (brand name) or $200 (generic) per 30-day supply within 60 days of market introduction, and newly acquired drugs priced over $100 (brand name) or $50 (generic) per 30-day supply at least 60 days before acquisition.

Directs the Commissioner to post reported information on the department website 30 days before price changes take effect in an easy-to-read format, with public comment period of at least 30 days.

Establishes civil penalties up to $10,000 per day of violation for manufacturers failing to submit timely reports, provide required information, or provide inaccurate or incomplete information, with collected penalties deposited in the health care access fund.